在排水淋巴结和瘤微环境中的瘤特异性CD8+ T细胞的功能子集
Qizhao Huang1, Lifan Xu2, Lilin Ye3
1Institute of Immunological Innovation and Translation, Chongqing Medical University, Chongqing, China; Guangdong Provincial Key Laboratory of Immune Regulation and Immunotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Current opinion in immunology
|November 26, 2024
概括
淋巴结中的瘤特异性CD8+ T细胞是PD-1/PD-L1阻塞有效性的关键. 然而,它们的分化轨迹可能导致T细胞耗尽和免疫治疗后复发.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
- T细胞生物学T细胞生物学
背景情况:
- 瘤排水淋巴结 (TdLN) 中的瘤特异性CD8+ T细胞作为瘤微环境 (TME) 中耗尽的T细胞子集的关键储存库.
- 这种储存库包括原始体耗尽的CD8+ T (TPEX) 细胞和新发现的瘤特异性记忆 (TTSM) 子集,这些子集对于抗瘤反应至关重要.
研究的目的:
- 研究TPEX和TTSM细胞在调解PD-1/PD-L1免疫检查点阻塞 (ICB) 的抗瘤作用中的时空作用.
- 探索TdLN和TME中瘤特异性CD8+ T细胞的表型和功能异质性.
- 讨论改善ICB疗效和克服治疗耐药性的影响.
主要方法:
- 对瘤特异性CD8+T细胞子集现有文献的综述.
- 在ICB治疗下对T细胞分化轨迹的分析.
- 专注于TdLN和TME中的表型和功能特征.
主要成果:
- PD-1/PD-L1 ICB促进了TPEX和TTSM细胞的增殖和分化.
- ICB不会改变从TTSM到TPEX细胞的分化途径,从而导致终端枯竭.
- 这种编程差异化可能解释了初始ICB治疗后患者频繁复发的原因.
结论:
- 了解瘤特异性CD8+ T细胞的异质性和动态对于优化ICB至关重要.
- 准T细胞分化轨迹可以防止疲并增强长期抗瘤免疫力.
- 需要新的策略来克服ICB耐药性,并改善癌症免疫治疗患者的结果.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
T Cell Activation and Clonal Selection
669
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
669
T Cell Types and Functions
954
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
954
Cytotoxic T Cells-mediated Immune Response
849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849


